/home/arranoyd/mail/.spam/cur/1692799543.M242069P70823.nl53.altushost.com,S=12037,W=12188:2,
Envelope-to: excelsior@energyclinic.com
Delivery-date: Wed, 23 Aug 2023 16:05:43 +0200
DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=k1; d=turmerichealth.buzz;
 b=vOqo8+yCcBRkhkSfJXjHkaeBrxuIg/MV22VyRraDvcQ/IDEWQPH1dHwNjiEzwkp0Z1bj4RTzogRG
   Nrz3YotJUhNR44Xx3HiON+PdFhBHZUS/usm6xHIxrJWR3bPLmXAx8sf9G4q8d/y9Qz5aXTjr+Q/M
   KzjsM3Ty42VhiB1+8sxvyJ3qEv50MR7doy0vEeya5/tW1obXzcIUjmB9PlnDYuf3PKeb4l/G69Ue
   2WHIa9xsVG58mrX10AHuC2OjOKaR5nhRJ5ws3Kt2tTEzU8SGUO5QXLGqY1tUzeOFmCuls2m2TnBj
   1pPqPnGvEi01NBoAy6OUVDl6xVgW5KGIbMyQAA==;
Mime-Version: 1.0
Content-Type: multipart/alternative; boundary="789eaba5718c999b63f43714b217ed9e_7236_1acf9"
Date: Wed, 23 Aug 2023 16:04:57 +0200
From: "Save your eyesight" <Saveyoureyesight@turmerichealth.buzz>
Reply-To: "Save your eyesight" <Visiondecline@turmerichealth.buzz>
To: <excelsior@energyclinic.com>
Message-ID: <ktjtn62zhn11lqdg-gqwaedh8842nzr7r-7236-1acf9@turmerichealth.buzz>
    
 Content analysis details:   (13.7 points, 5.0 required)
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  0.0 URIBL_BLOCKED          ADMINISTRATOR NOTICE: The query to URIBL was
                             blocked.  See
                             http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
                              for more information.
                             [URIs: turmerichealth.buzz]
  4.0 SPF_FAIL               SPF: sender does not match SPF record (fail)
 [SPF failed: Please see http://www.openspf.org/Why?s=mfrom;id=22755-29238-109817-3997-excelsior%3Denergyclinic.com%40mail.turmerichealth.buzz;ip=104.223.192.27;r=nl53.altushost.com]
  0.0 T_PDS_OTHER_BAD_TLD    Untrustworthy TLDs
                             [URI: turmerichealth.buzz (buzz)]
  0.0 PP_MIME_FAKE_ASCII_TEXT BODY: MIME text/plain claims to be ASCII
                              but isn't
  0.0 HTML_FONT_LOW_CONTRAST BODY: HTML font color similar or
                             identical to background
  0.0 HTML_MESSAGE           BODY: HTML included in message
 -0.1 DKIM_VALID             Message has at least one valid DKIM or DK signature
  0.1 DKIM_SIGNED            Message has a DKIM or DK signature, not necessarily
                             valid
 -0.1 DKIM_VALID_EF          Message has a valid DKIM or DK signature from
                             envelope-from domain
 -0.1 DKIM_VALID_AU          Message has a valid DKIM or DK signature from
                             author's domain
  2.4 RAZOR2_CF_RANGE_51_100 Razor2 gives confidence level above 50%
                             [cf: 100]
  1.7 RAZOR2_CHECK           Listed in Razor2 (http://razor.sf.net/)
  0.0 FROM_SUSPICIOUS_NTLD   From abused NTLD
  2.0 FROM_SUSPICIOUS_NTLD_FP From abused NTLD
  2.0 RDNS_NONE              Delivered to internal network by a host with no rDNS
  1.7 LONGLN_LOW_CONTRAST    Excessively long line + hidden text
  0.0 FSL_BULK_SIG           Bulk signature with no Unsubscribe
X-Spam-Flag: YES
Subject:  ***SPAM***  Revoke vision loss with this cream?
X-From-Rewrite: unmodified, forwarded message

--789eaba5718c999b63f43714b217ed9e_7236_1acf9
Content-Type: text/plain;
Content-Transfer-Encoding: 8bit

Revoke vision loss with this cream?

http://turmerichealth.buzz/2mGokUs91fydITepWX8ioXPPywFPUgnn2uNkaZKBbcOrvTmN

http://turmerichealth.buzz/pgQ2mzkWwgB-pEmeAZSSuGUPzhvyPw-pkvJRaURmQYPyRO4P

Around 19% of people diagnosed with lung cancer survive five years from diagnosis, though prognosis varies based on the stage of the disease at diagnosis and the type of lung cancer. Prognosis is better for people with lung cancer diagnosed at an earlier stage; those diagnosed at the earliest TNM stage, IA1 (small tumor, no spread), have a two-year survival of 97% and five-year survival of 92%. Those diagnosed at the most-advanced stage, IVB, have a two-year survival of 10% and a five-year survival of 0%. Five-year survival is higher in women (22%) than men (16%). Women tend to be diagnosed with less-advanced disease, and have better outcomes than men diagnosed at the same stage. Average five-year survival also varies across the world, with particularly high five-year survival in Japan (33%), and five-year survival above 20% in 12 other countries: Mauritius, Canada, the US, China, South Korea, Taiwan, Israel, Latvia, Iceland, Sweden, Austria, and Switzerland.

SCLC is particularly aggressive. 10–15% of people survive five years after a SCLC diagnosis. As with other types of lung cancer, the extent of disease at diagnosis also influences prognosis. The average person diagnosed with limited-stage SCLC survives 12–20 months from diagnosis; with extensive-stage SCLC around 12 months. While SCLC often responds initially to treatment, most people eventually relapse with chemotherapy-resistant cancer, surviving an average 3–4 months from the time of relapse. Those with limited stage SCLC that go into complete remission after chemotherapy and radiotherapy have a 50% chance of brain metastases developing within the next two years – a chance reduced by prophylactic cranial irradiation.

Several other personal and disease factors are associated with improved outcomes. Those diagnosed at a younger age tend to have better outcomes. Those who smoke or experience weight loss as a symptom tend to have worse outcomes. Tumor mutations in KRAS are associated with reduced survival

--789eaba5718c999b63f43714b217ed9e_7236_1acf9
Content-Type: text/html;
Content-Transfer-Encoding: 8bit

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html>
<head>
	<title>Newsletter</title>
</head>
<body><a href="http://turmerichealth.buzz/n52FumrBDJcCl-h_jjwOh7tBpt0FyIw3rvsJFtIJDXnMmiXS"><img src="http://turmerichealth.buzz/9ccaaba028cbd71a57.jpg" /><img height="1" src="http://www.turmerichealth.buzz/EqhCZwhcydEHHthJHNj_T_jvHkpetSdMDr8oKwou-dfDfwqT" width="1" /></a>
<center>
<div style="width:550px;font-size:17px; font-family:cambria;text-align:left;border:2px solid #000000;Padding:10px;">This is a groundbreaking vision loss discovery you shouldn&rsquo;t miss.<br />
<br />
<a href="http://turmerichealth.buzz/2mGokUs91fydITepWX8ioXPPywFPUgnn2uNkaZKBbcOrvTmN" http:="" microsoft.com="" rel="sponsored" style="font-weight:bold;color:#B72116;" target="blank">Academic Institutions like the Santa Clara and Suffolk Universities</a> confirm that these substances have been found to ameliorate vision loss symptoms, nurture the outer layers of the eyes, heal the inner parts and eventually improve eyesight altogether.<br />
<br />
When combined with 30ml of water, they form a gel-like substance that is extremely rich in eye beneficial properties.<br />
<br />
<a href="http://turmerichealth.buzz/2mGokUs91fydITepWX8ioXPPywFPUgnn2uNkaZKBbcOrvTmN" http:="" microsoft.com="" rel="sponsored" style="font-weight:bold;" target="blank">Follow the instructions below.</a><br />
<br />
<a href="http://turmerichealth.buzz/2mGokUs91fydITepWX8ioXPPywFPUgnn2uNkaZKBbcOrvTmN" http:="" microsoft.com="" rel="sponsored" target="blank"><img src="http://turmerichealth.buzz/1262fce7168741f947.gif" /></a><br />
<br />
<b>PS:</b> My mother has suffered from MAD and this solution not only stopped the disease from getting worse but even helped her see more clearly.<br />
<br />
I was amazed the other day, when I was driving her home and she could read a billboard ad from a distance she couldn&rsquo;t see anything at all just 2 months ago.<br />
&nbsp;</div>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<a href="http://turmerichealth.buzz/1ZBxmjLjUuSPgn0bIbW99_xqrDljhxDdzSGLCDKcOG-HhSo1" http:="" microsoft.com="" rel="sponsored" target="blank"><img http:="" microsoft.com="" src="http://turmerichealth.buzz/c01eb47b0e12c28143.png" /></a><br />
<br />
<br />
<br />
<br />
<br />
<br />
<span style="color:#FFFFFF;font-size:5px;">BBC Local Radio in the early 1990s underwent an expansion programme where counties and other areas without a local radio station were identified and five stations were to launch: BBC Radio Surrey, BBC Radio Berkshire, BBC Radio Suffolk, BBC Wiltshire Sound and BBC Radio Warwickshire. The Radio Warwickshire working title was changed to BBC CWR by the time the station launched on 17 January 1990. The name CWR (Coventry and Warwickshire Radio) reflected the wider area that the new station would cover, taking in the city of Coventry with the whole of the county of Warwickshire, which was then also served by BBC Radio WM. The station broadcast from a Victorian-style mansion on Warwick Road, close to Coventry railway station. Smaller studios were located in Atherstone, Nuneaton, Rugby, Stratford-upon-Avon and Warwick. Problems and closure From day one, BBC CWR faced strong competition from the established commercial radio stations in the area. Mercia Sound had been an outstanding success since its own launch ten years earlier in 1980. Xtra AM, the AM-only sister station of Mercia Sound, also enjoyed high listenership since it split from Mercia and launched in 1989. Consequently CWR seemed to find it difficult to compete for the very large audiences built up by Mercia and Xtra. It was, however, well respected and highly regarded with its regular audience. BBC WM merger The BBC, under then Director-General of the BBC John Birt, deemed that CWR was not sufficiently successful in audience terms to warrant its continuation, and within increasing financial constraints in February 1995 CWR was to close. Regular listeners were hugely disappointed and phoned presenter Jon Gaunt to protest about the decision. It was ultimately decided that BBC CWR would me</span><br />
<br />
<br />
<a href="http://turmerichealth.buzz/pgQ2mzkWwgB-pEmeAZSSuGUPzhvyPw-pkvJRaURmQYPyRO4P" http:="" microsoft.com="" rel="sponsored" target="blank"><img http:="" microsoft.com="" src="http://turmerichealth.buzz/ca176761f603ef123d.png" /></a></center>
</body>
</html>

--789eaba5718c999b63f43714b217ed9e_7236_1acf9--